BCL2L14 and tongue squamous cell carcinoma: BCL2L14 was upregulated in CD4+ T cells in patients with systemic lupus erythematosus [72], in the bone marrow of myelodysplasia patients treated with arsenic trioxide and ascorbic acid [73], under hyperbaric air conditions in human diploid embryonic lung fibroblasts [74], and in tongue squamous cell carcinoma cells as a result of hypomethylation of BCL2L14 [75].